Range
5.57 - 6
Vol / Avg.
137.4K/56.6K
Div / Yield
-
52 Wk
4.15 - 16.22
Mkt Cap
131.7M
Payout Ratio
-
Open
5.97
P/E
-
EPS
-0.53
Shares
23.2M
Outstanding
23.2M
Total Float
20M
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q4 2021Est.ActualSurprise
EPS
(EXPECTED)2022-02-20
REV
Q3 2021Est.ActualSurprise
EPS-0.380-0.530 -0.1500
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Elevation Oncology Questions & Anwsers

Q

How do I buy Elevation Oncology (ELEV) stock?

A

You can purchase shares of Elevation Oncology (NASDAQ: ELEV) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Elevation Oncology's (ELEV) competitors?

Q

What is the target price for Elevation Oncology (ELEV) stock?

A

The latest price target for Elevation Oncology (NASDAQ: ELEV) was reported by HC Wainwright & Co. on December 23, 2021. The analyst firm set a price target for 12.00 expecting ELEV to rise to within 12 months (a possible 111.64% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Elevation Oncology (ELEV)?

A

The stock price for Elevation Oncology (NASDAQ: ELEV) is $5.67 last updated Fri Jan 21 2022 21:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Elevation Oncology (ELEV) pay a dividend?

A

There are no upcoming dividends for Elevation Oncology.

Q

When is Elevation Oncology (NASDAQ:ELEV) reporting earnings?

A

Elevation Oncology’s $Q4 earnings are confirmed for after-market on February 20, 2022.

Q

Is Elevation Oncology (ELEV) going to split?

A

There is no upcoming split for Elevation Oncology.

Q

What sector and industry does Elevation Oncology (ELEV) operate in?

A

Elevation Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.